{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:49:25Z","timestamp":1792784965938,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K23 AG062750"],"award-info":[{"award-number":["K23 AG062750"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K23 AG084868"],"award-info":[{"award-number":["K23 AG084868"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AG036694"],"award-info":[{"award-number":["P01 AG036694"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AG036694"],"award-info":[{"award-number":["P01 AG036694"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG071865"],"award-info":[{"award-number":["R01 AG071865"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Philanthropic gift from the Shelby Cullom Davis Charitable Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-71269-3","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:04:37Z","timestamp":1776157477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Plasma phosphorylated tau 217 and longitudinal trajectories of A\u03b2, tau, and cognition in cognitively unimpaired older adults"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8318-0443","authenticated-orcid":false,"given":"Hyun-Sik","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana A. U.","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7597-7647","authenticated-orcid":false,"given":"Wai-Ying Wendy","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7510-5835","authenticated-orcid":false,"given":"Andrea M.","family":"Rom\u00e1n Viera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Maa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Kirn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-2372","authenticated-orcid":false,"given":"Michael J.","family":"Properzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Bellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2706-3218","authenticated-orcid":false,"given":"Michelle E.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7620-3822","authenticated-orcid":false,"given":"Heidi I. L.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5356-5537","authenticated-orcid":false,"given":"Rachel F.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn V.","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad A.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Amariglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorene M.","family":"Rentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4604-4629","authenticated-orcid":false,"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8846-9767","authenticated-orcid":false,"given":"Dennis J.","family":"Selkoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4793-564X","authenticated-orcid":false,"given":"Philip B.","family":"Verghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel B.","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1535-6133","authenticated-orcid":false,"given":"Reisa A.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7792-1698","authenticated-orcid":false,"given":"Jasmeer P.","family":"Chhatwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"71269_CR1","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","volume":"20","author":"Alzheimer's Association","year":"2024","unstructured":"Alzheimer's Association. 2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 20, 3708\u20133821 (2024).","journal-title":"Alzheimers Dement"},{"key":"71269_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in Early Alzheimer\u2019s Disease. N. Engl. J. Med 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med"},{"key":"71269_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims, J. R. et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA 330, 512\u2013527 (2023).","journal-title":"JAMA"},{"key":"71269_CR4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jamaneurol.2023.0199","volume":"80","author":"S Janelidze","year":"2023","unstructured":"Janelidze, S., Barthelemy, N. R., He, Y., Bateman, R. J. & Hansson, O. Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios. JAMA Neurol. 80, 516\u2013522 (2023).","journal-title":"JAMA Neurol."},{"key":"71269_CR5","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jama.2024.13855","volume":"332","author":"S Palmqvist","year":"2024","unstructured":"Palmqvist, S. et al. Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care. JAMA 332, 1245\u20131257 (2024).","journal-title":"JAMA"},{"key":"71269_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist, S. et al. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA 324, 772\u2013781 (2020).","journal-title":"JAMA"},{"key":"71269_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-023-02570-4","volume":"146","author":"L Yu","year":"2023","unstructured":"Yu, L. et al. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults. Acta Neuropathol. 146, 1\u201311 (2023).","journal-title":"Acta Neuropathol."},{"key":"71269_CR8","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","volume":"30","author":"NR Barthelemy","year":"2024","unstructured":"Barthelemy, N. R. et al. Highly accurate blood test for Alzheimer\u2019s disease is similar or superior to clinical cerebrospinal fluid tests. Nat. Med 30, 1085\u20131095 (2024).","journal-title":"Nat. Med"},{"key":"71269_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13859","author":"CR Jack Jr.","year":"2024","unstructured":"Jack, C. R. Jr. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement https:\/\/doi.org\/10.1002\/alz.13859 (2024).","journal-title":"Alzheimers Dement"},{"key":"71269_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","volume":"84","author":"R Sperling","year":"2014","unstructured":"Sperling, R., Mormino, E. & Johnson, K. The evolution of preclinical Alzheimer\u2019s disease: implications for prevention trials. Neuron 84, 608\u2013622 (2014).","journal-title":"Neuron"},{"key":"71269_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling, R. A. et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7, 280\u2013292 (2011).","journal-title":"Alzheimers Dement"},{"key":"71269_CR12","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","volume":"389","author":"RA Sperling","year":"2023","unstructured":"Sperling, R. A. et al. Trial of Solanezumab in Preclinical Alzheimer\u2019s Disease. N. Engl. J. Med 389, 1096\u20131107 (2023).","journal-title":"N. Engl. J. Med"},{"key":"71269_CR13","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/alz.12748","volume":"19","author":"MS Rafii","year":"2023","unstructured":"Rafii, M. S. et al. The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer\u2019s disease. Alzheimers Dement 19, 1227\u20131233 (2023).","journal-title":"Alzheimers Dement"},{"key":"71269_CR14","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","volume":"28","author":"NJ Ashton","year":"2022","unstructured":"Ashton, N. J. et al. Differential roles of Abeta42\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring. Nat. Med 28, 2555\u20132562 (2022).","journal-title":"Nat. Med"},{"key":"71269_CR15","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1093\/brain\/awaa286","volume":"143","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren, N. et al. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer\u2019s disease. Brain 143, 3234\u20133241 (2020).","journal-title":"Brain"},{"key":"71269_CR16","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/alz.13542","volume":"20","author":"RA Rissman","year":"2024","unstructured":"Rissman, R. A. et al. Plasma Abeta42\/Abeta40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer\u2019s disease. Alzheimers Dement 20, 1214\u20131224 (2024).","journal-title":"Alzheimers Dement"},{"key":"71269_CR17","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1001\/jamaneurol.2024.2619","volume":"81","author":"S Janelidze","year":"2024","unstructured":"Janelidze, S. et al. Plasma Phosphorylated Tau 217 and Abeta42\/40 to Predict Early Brain Abeta Accumulation in People Without Cognitive Impairment. JAMA Neurol. 81, 947\u2013957 (2024).","journal-title":"JAMA Neurol."},{"key":"71269_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14629","volume":"21","author":"PM Cogswell","year":"2025","unstructured":"Cogswell, P. M. et al. Plasma Alzheimer\u2019s disease biomarker relationships with incident abnormal amyloid PET. Alzheimers Dement 21, e14629 (2025).","journal-title":"Alzheimers Dement"},{"key":"71269_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad057","volume":"5","author":"EM Jonaitis","year":"2023","unstructured":"Jonaitis, E. M. et al. Plasma phosphorylated tau 217 in preclinical Alzheimer\u2019s disease. Brain Commun. 5, fcad057 (2023).","journal-title":"Brain Commun."},{"key":"71269_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuroimage.2015.03.069","volume":"144","author":"A Dagley","year":"2017","unstructured":"Dagley, A. et al. Harvard Aging Brain Study: Dataset and accessibility. Neuroimage 144, 255\u2013258 (2017).","journal-title":"Neuroimage"},{"key":"71269_CR21","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1002\/alz.13764","volume":"20","author":"MR Meyer","year":"2024","unstructured":"Meyer, M. R. et al. Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Abeta42\/40 ratio to identify presence of brain amyloid. Alzheimers Dement 20, 3179\u20133192 (2024).","journal-title":"Alzheimers Dement"},{"key":"71269_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson, K. A. et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann. Neurol. 79, 110\u2013119 (2016).","journal-title":"Ann. Neurol."},{"key":"71269_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/bpa.12505","volume":"28","author":"VD Smith","year":"2018","unstructured":"Smith, V. D. et al. Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi. Brain Pathol. 28, 264\u2013273 (2018).","journal-title":"Brain Pathol."},{"key":"71269_CR24","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw, B. J. et al. Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study. JAMA Neurol. 76, 915\u2013924 (2019).","journal-title":"JAMA Neurol."},{"key":"71269_CR25","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/s41591-023-02443-z","volume":"29","author":"K Horie","year":"2023","unstructured":"Horie, K. et al. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer\u2019s disease. Nat. Med 29, 1954\u20131963 (2023).","journal-title":"Nat. Med"},{"key":"71269_CR26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.14283\/jpad.2024.124","volume":"11","author":"D Molina-Henry","year":"2024","unstructured":"Molina-Henry, D. et al. Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4. J. Prev. Alzheimers Dis. 11, 831\u2013837 (2024).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"71269_CR27","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett, D. A. et al. Religious Orders Study and Rush Memory and Aging Project. J. Alzheimers Dis. 64, S161\u2013S189 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"71269_CR28","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris, J. C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412\u20132414 (1993).","journal-title":"Neurology"},{"key":"71269_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E. & McHugh, P. R. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res 12, 189\u2013198 (1975).","journal-title":"J. Psychiatr. Res"},{"key":"71269_CR30","unstructured":"Wechsler, D. WMS-R: Wechsler Memory Scale\u2013Revised: manual. (Psychological Corp.: Harcourt Brace Jovanovich, 1987)."},{"key":"71269_CR31","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1212\/WNL.0000000000011214","volume":"96","author":"ME Farrell","year":"2021","unstructured":"Farrell, M. E. et al. Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation. Neurology 96, e619\u2013e631 (2021).","journal-title":"Neurology"},{"key":"71269_CR32","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1212\/WNL.0000000000000431","volume":"82","author":"EC Mormino","year":"2014","unstructured":"Mormino, E. C. et al. Amyloid and APOE epsilon4 interact to influence short-term decline in preclinical Alzheimer disease. Neurology 82, 1760\u20131767 (2014).","journal-title":"Neurology"},{"key":"71269_CR33","first-page":"904","volume":"39","author":"OG Rousset","year":"1998","unstructured":"Rousset, O. G., Ma, Y. & Evans, A. C. Correction for partial volume effects in PET: principle and validation. J. Nucl. Med 39, 904\u2013911 (1998).","journal-title":"J. Nucl. Med"},{"key":"71269_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl, B. et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341\u2013355 (2002).","journal-title":"Neuron"},{"key":"71269_CR35","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.trci.2017.10.004","volume":"3","author":"KV Papp","year":"2017","unstructured":"Papp, K. V., Rentz, D. M., Orlovsky, I., Sperling, R. A. & Mormino, E. C. Optimizing the preclinical Alzheimer\u2019s cognitive composite with semantic processing: The PACC5. Alzheimers Dement (N.Y.) 3, 668\u2013677 (2017).","journal-title":"Alzheimers Dement (N.Y.)"},{"key":"71269_CR36","unstructured":"Wechsler, D. Wechsler adult intelligence scale: WAIS-R manual. Rev. edn, (Harcourt Brace Jovanovich for The Psychological Corporation, 1981)."},{"key":"71269_CR37","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1212\/WNL.54.4.827","volume":"54","author":"E Grober","year":"2000","unstructured":"Grober, E., Lipton, R. B., Hall, C. & Crystal, H. Memory impairment on free and cued selective reminding predicts dementia. Neurology 54, 827\u2013832 (2000).","journal-title":"Neurology"},{"key":"71269_CR38","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1001\/archneur.1992.00530360051017","volume":"49","author":"AU Monsch","year":"1992","unstructured":"Monsch, A. U. et al. Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch. Neurol. 49, 1253\u20131258 (1992).","journal-title":"Arch. Neurol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71269-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71269-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71269-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:04:41Z","timestamp":1776157481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71269-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["71269"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-71269-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Philip B. Verghese and Joel B. Braunstein are full-time employees of C2N Diagnostics LLC. Other authors declare no directly relevant conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3188"}}